224 related articles for article (PubMed ID: 9482732)
1. RhoA effector mutants reveal distinct effector pathways for cytoskeletal reorganization, SRF activation and transformation.
Sahai E; Alberts AS; Treisman R
EMBO J; 1998 Mar; 17(5):1350-61. PubMed ID: 9482732
[TBL] [Abstract][Full Text] [Related]
2. Cellular functions of TC10, a Rho family GTPase: regulation of morphology, signal transduction and cell growth.
Murphy GA; Solski PA; Jillian SA; Pérez de la Ossa P; D'Eustachio P; Der CJ; Rush MG
Oncogene; 1999 Jul; 18(26):3831-45. PubMed ID: 10445846
[TBL] [Abstract][Full Text] [Related]
3. Rit, a non-lipid-modified Ras-related protein, transforms NIH3T3 cells without activating the ERK, JNK, p38 MAPK or PI3K/Akt pathways.
Rusyn EV; Reynolds ER; Shao H; Grana TM; Chan TO; Andres DA; Cox AD
Oncogene; 2000 Sep; 19(41):4685-94. PubMed ID: 11032018
[TBL] [Abstract][Full Text] [Related]
4. [Serum response factor participates in RhoA-induced endothelial cell F-actin rearrangements].
Han YL; Yu HB; Yan CH; Meng ZM; Zhang XL; Kang J; Li SH; Wang SW
Sheng Li Xue Bao; 2005 Jun; 57(3):295-302. PubMed ID: 15968423
[TBL] [Abstract][Full Text] [Related]
5. Activation of RhoA and SAPK/JNK signalling pathways by the RhoA-specific exchange factor mNET1.
Alberts AS; Treisman R
EMBO J; 1998 Jul; 17(14):4075-85. PubMed ID: 9670022
[TBL] [Abstract][Full Text] [Related]
6. LIM kinase and Diaphanous cooperate to regulate serum response factor and actin dynamics.
Geneste O; Copeland JW; Treisman R
J Cell Biol; 2002 May; 157(5):831-8. PubMed ID: 12034774
[TBL] [Abstract][Full Text] [Related]
7. Cytoskeletal organization in tropomyosin-mediated reversion of ras-transformation: Evidence for Rho kinase pathway.
Shah V; Bharadwaj S; Kaibuchi K; Prasad GL
Oncogene; 2001 Apr; 20(17):2112-21. PubMed ID: 11360195
[TBL] [Abstract][Full Text] [Related]
8. Effector domain mutants of Rho dissociate cytoskeletal changes from nuclear signaling and cellular transformation.
Zohar M; Teramoto H; Katz BZ; Yamada KM; Gutkind JS
Oncogene; 1998 Aug; 17(8):991-8. PubMed ID: 9747878
[TBL] [Abstract][Full Text] [Related]
9. The insert region of RhoA is essential for Rho kinase activation and cellular transformation.
Zong H; Kaibuchi K; Quilliam LA
Mol Cell Biol; 2001 Aug; 21(16):5287-98. PubMed ID: 11463812
[TBL] [Abstract][Full Text] [Related]
10. Rac regulation of transformation, gene expression, and actin organization by multiple, PAK-independent pathways.
Westwick JK; Lambert QT; Clark GJ; Symons M; Van Aelst L; Pestell RG; Der CJ
Mol Cell Biol; 1997 Mar; 17(3):1324-35. PubMed ID: 9032259
[TBL] [Abstract][Full Text] [Related]
11. Molecular decipherment of Rho effector pathways regulating tight-junction permeability.
Fujita H; Katoh H; Hasegawa H; Yasui H; Aoki J; Yamaguchi Y; Negishi M
Biochem J; 2000 Mar; 346 Pt 3(Pt 3):617-22. PubMed ID: 10698687
[TBL] [Abstract][Full Text] [Related]
12. Distinct expression patterns and transforming properties of multiple isoforms of Ost, an exchange factor for RhoA and Cdc42.
Lorenzi MV; Castagnino P; Chen Q; Hori Y; Miki T
Oncogene; 1999 Aug; 18(33):4742-55. PubMed ID: 10467422
[TBL] [Abstract][Full Text] [Related]
13. TIM, a Dbl-related protein, regulates cell shape and cytoskeletal organization in a Rho-dependent manner.
Xie X; Chang SW; Tatsumoto T; Chan AM; Miki T
Cell Signal; 2005 Apr; 17(4):461-71. PubMed ID: 15601624
[TBL] [Abstract][Full Text] [Related]
14. Actin cytoskeleton dynamics promotes leptin-induced vascular smooth muscle hypertrophy via RhoA/ROCK- and phosphatidylinositol 3-kinase/protein kinase B-dependent pathways.
Zeidan A; Paylor B; Steinhoff KJ; Javadov S; Rajapurohitam V; Chakrabarti S; Karmazyn M
J Pharmacol Exp Ther; 2007 Sep; 322(3):1110-6. PubMed ID: 17562852
[TBL] [Abstract][Full Text] [Related]
15. Transformation mediated by RhoA requires activity of ROCK kinases.
Sahai E; Ishizaki T; Narumiya S; Treisman R
Curr Biol; 1999 Feb; 9(3):136-45. PubMed ID: 10021386
[TBL] [Abstract][Full Text] [Related]
16. A role for VASP in RhoA-Diaphanous signalling to actin dynamics and SRF activity.
Grosse R; Copeland JW; Newsome TP; Way M; Treisman R
EMBO J; 2003 Jun; 22(12):3050-61. PubMed ID: 12805219
[TBL] [Abstract][Full Text] [Related]
17. Role of RhoA/ROCK-dependent actin contractility in the induction of tenascin-C by cyclic tensile strain.
Sarasa-Renedo A; Tunç-Civelek V; Chiquet M
Exp Cell Res; 2006 May; 312(8):1361-70. PubMed ID: 16448650
[TBL] [Abstract][Full Text] [Related]
18. The diaphanous-related formin mDia1 controls serum response factor activity through its effects on actin polymerization.
Copeland JW; Treisman R
Mol Biol Cell; 2002 Nov; 13(11):4088-99. PubMed ID: 12429848
[TBL] [Abstract][Full Text] [Related]
19. Distinct involvement of cdc42 and RhoA GTPases in actin organization and cell shape in untransformed and Dbl oncogene transformed NIH3T3 cells.
Olivo C; Vanni C; Mancini P; Silengo L; Torrisi MR; Tarone G; Defilippi P; Eva A
Oncogene; 2000 Mar; 19(11):1428-36. PubMed ID: 10723134
[TBL] [Abstract][Full Text] [Related]
20. Ornithine decarboxylase induction in transformation by H-Ras and RhoA.
Shantz LM; Pegg AE
Cancer Res; 1998 Jul; 58(13):2748-53. PubMed ID: 9661886
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
